Department of Oral Pathology and Microbiology, Ambika Dental Clinic and Oral Histopathology Laboratory, Attohid Park, Rahadpor, Bharuch, Gujarat, India.
Professor and Head, Department of Oral Pathology and Microbiology, Manipal College of Dental Sciences, Light House Hill Road, Manipal University, Mangalore, Karnataka, India.
J Cancer Res Ther. 2023 Apr;19(Supplement):S198-S205. doi: 10.4103/jcrt.JCRT_1641_20.
Tumour-Node-Metastasis (TNM) staging has been widely used for treatment planning and prognostication of oral cancers; however, TNM staging system alone is insufficient for optimal prognostication. A combined assessment of clinical staging and cytomorphology might serve as a more specific measure for prognostication. The present study attempted to compare the efficacy of histologic grading systems (Jakobbson et al., Anneroth et al. and Bryne et al.) of malignancy in determining the nature and prognosis of oral squamous cell carcinoma (OSCC). Tumour protein (TP53) immunohistochemical marker was used to determine the aggressiveness of OSCC.
Tissue sections from 24 biopsy-proven cases of OSCC were stained with anti-TP53 antibody. Hundred cells in each case were counted and tabulated. Cases were graded using three histopathological grading systems. Findings were compared and correlated with TP53 immunopositivity and clinical parameters.
Positive correlation was observed between TP53 immunostaining and grading scores of each system. Highest correlation was observed with Jakobbson et al. grading system (r value = 0.91, P < 0.001). Significant results were observed on comparing grades of Jakobsson et al., Anneroth et al. and Bryne et al. grading system with segregated groups of TP53 immunopositive cases (P = 0.004, P = 0.003, P = 0.001, respectively). No significant results were observed on comparing grades of histopathological systems with clinical parameters.
Both, clinical and histopathological grading systems, with immunohistochemistry, should be taken into account during the assessment of OSCC, for treatment planning and better prediction of tumour prognosis.
肿瘤-淋巴结-转移(TNM)分期已广泛用于口腔癌的治疗计划和预后评估;然而,单独的 TNM 分期系统不足以进行最佳预后评估。临床分期和细胞形态学的综合评估可能是一种更具特异性的预后指标。本研究试图比较恶性肿瘤的组织学分级系统(Jakobbson 等、Anneroth 等和 Bryne 等)在确定口腔鳞状细胞癌(OSCC)的性质和预后方面的疗效。肿瘤蛋白(TP53)免疫组化标志物用于确定 OSCC 的侵袭性。
对 24 例经活检证实的 OSCC 组织切片进行抗 TP53 抗体染色。对每个病例中的 100 个细胞进行计数和制表。使用三种组织病理学分级系统对病例进行分级。比较结果并与 TP53 免疫阳性和临床参数相关联。
TP53 免疫染色与每个系统的分级评分之间存在正相关。与 Jakobsson 等分级系统的相关性最高(r 值=0.91,P<0.001)。在比较 Jakobsson 等、Anneroth 等和 Bryne 等分级系统的分级与 TP53 免疫阳性病例的分组时,观察到显著结果(P=0.004、P=0.003、P=0.001)。在比较组织病理学系统的分级与临床参数时,未观察到显著结果。
在评估 OSCC 时,应考虑临床和组织病理学分级系统,并结合免疫组织化学,以进行治疗计划和更好地预测肿瘤预后。